A Study to Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Kidney Function in Subjects With Type 2 Diabetes and Chronic Kidney Disease With Protein in Their Urine.

Clinical trial NCT01464320 · COMPLETED

Trial details

NCT number: NCT01464320
Sponsor: Abbott
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetics, Chronic Kidney Disease, Protein in Urine

Start date: 2011-11-01
Primary completion: 2012-04-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.